Dr. Borghaei is Chief of Thoracic Medical Oncology and Director of Lung Cancer Risk Assessment at Fox Chase Cancer Center in Philadelphia, PA. He is Board Certified in Medical Oncology, as well as certified by the National Board of Osteopathic Medical Examiners.
Dr. Borghaei received his DO from the Philadelphia College of Osteopathic Medicine and completed his fellowship at Fox Chase Cancer Center and then joined the Center’s Department of Medical Oncology in 2004.
As a medical oncologist, Dr. Borghaei specializes in the diagnosis and treatment of lung cancer—with an additional interest in lung cancer prevention. His practice focuses on offering clinical trials with a concentration on antibodies and other immune-based therapies. Dr. Borghaei’s laboratory research concentrates on the production of monoclonal antibodies against novel targets in tumor blood vessels. These antibodies have the potential for use in the treatment of various cancers, as well as for research on the role that the body’s immune system plays in the fight against cancer. Dr. Borghaei is also an active member of a number of professional societies, including the American Association for Cancer Research, American Society of Clinical Oncology and ECOG’s core thoracic committee.
- Chief, Thoracic Medical Oncology
Director, Lung Cancer Risk Assessment
Fox Chase Cancer Center